AetnaAll Plans · Coverage · Medical Policy · OB-GYNMedium impact
Hypertensive Disorders of Pregnancy (CPB 0368, reviewed 2026-05-22)
Effective date
Not stated in the notice
Identified
Aug 19, 2026
Summary
Aetna considers obstetrical hypertension programs experimental, investigational, or unproven because they have not been proven to be more effective than member self-management performed in concert with supervision by an obstetrician in reducing fetal or maternal morbidity and mortality. Aetna also considers PEPredictDx, a test for identifying women at high risk for pre-eclampsia, experimental, investigational, or unproven. CPT code 0390U and HCPCS codes S9211, S9212, and S9213 (home management of gestational hypertension, postpartum hypertension, and preeclampsia) are listed as not covered for the indications in this policy, and several ICD-10 codes for hypertension complicating pregnancy, gestational hypertension, preeclampsia, and eclampsia are also listed as not covered.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
01Billing team: Do not bill CPT 0390U or HCPCS S9211, S9212, or S9213 for the indications listed in this policy, because the policy lists them as not covered.
02Claims for the ICD-10 codes listed as not covered are also not covered for the indications listed in this policy.
03Obstetrical hypertension programs and PEPredictDx are experimental, investigational, or unproven under this policy, so services provided under those programs or for that test do not meet this policy's coverage criteria.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.